Navigation Links
New Alexander, the Elephant Who Couldn't Eat Peanuts DVDs Help Children With Food Allergies
Date:2/11/2008

in an emergency. Alex discovers just how much fun having a babysitter can be after his parents teach her all about his food allergies.

The first Alexander video, Alexander the Elephant Who Couldn't Eat Peanuts, introduced youngsters to Alexander 10 years ago. It was an engaging award winner that won critical acclaim from young viewers, parents, and educators. Children watched it over and over. That video spun off a series of books featuring Alexander and his friends, which has won its own awards. To date, there are 13 books in the series that examine how children with food allergies can stay safe while going out to eat, attending school, riding on an airplane, and going to a birthday party. All are beautifully illustrated in full color and are written for children ages 2 through 7 years.

Food allergy is a potentially fatal condition that affects more than 12 million Americans, or 1 in 25 - and 1 in 17 under age 3. It results in more than 30,000 emergency room visits each year and 150 to 200 deaths, which sometimes occur within minutes. The incidence of food allergy has doubled in the last 10 years, and scientists aren't sure why. Eight foods account for 90 percent of all food-allergic reactions in the U.S.: milk, eggs, peanuts, tree nuts, wheat, soy, fish, and shellfish. There is no known cure; strict avoidance is the only way to prevent a reaction.

"If the 3.1 million U.S. children who have food allergy were surveyed to find out their heroes, it's a good bet that Alexander the Elephant would figure prominently on that list," remarks Munoz-Furlong. "This charming pachyderm has shown them that they are not alone."

The original and current Alexander DVDs are produced by Susan Leavitt of Time Frame Productions, Inc., who has produced all of FAAN's educational videos. The animators are Bill and Colleen Davis of Artbear Pigmation, who have worked on projects for Sesame Street, Reading Rainbow, and Nickelodeon, among many other clients.
'/>"/>

SOURCE Food Allergy & Anaphylaxis Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Scientists Map Elephantiasis Parasites Genome
2. Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation
3. Elephant Ensemble Theater Brings New Production to Bronx Hospitals
4. Research finds allergic children exposed to peanuts at younger ages despite recommendations to avoid
5. Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study
6. Children of depressed moms do better when dad is involved, SLU researcher finds
7. High pollution linked to poor lung function growth in children in Mexico City
8. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
9. Obese Children Miss More School Days
10. Ultra-Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease
11. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 1CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3